
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of ME THERAPEUTICS HLDGS by ME THERAPEUTICS HLDGS INC. (OTCPK:METXF) through any online brokerage.
There are no as such competitors for ME THERAPEUTICS HLDGS by ME THERAPEUTICS HLDGS INC..
There is no analysis for ME THERAPEUTICS HLDGS by ME THERAPEUTICS HLDGS INC. to provide a consensus price target.
The stock price for ME THERAPEUTICS HLDGS by ME THERAPEUTICS HLDGS INC. (OTCPK: METXF) is $1.67 last updated September 9, 2026 at 9:37 AM EDT.
There are no upcoming dividends for ME THERAPEUTICS HLDGS by ME THERAPEUTICS HLDGS INC..
ME THERAPEUTICS HLDGS by ME THERAPEUTICS HLDGS INC. does not have any upcoming earnings scheduled.
There is no upcoming split for ME THERAPEUTICS HLDGS by ME THERAPEUTICS HLDGS INC..
ME THERAPEUTICS HLDGS by ME THERAPEUTICS HLDGS INC. is in the Healthcare sector and Biotechnology industry. They are listed on the OTCPK.
ME Therapeutics Holding Inc is a preclinical stage biotechnology company working on cancer-fighting drugs in the field of Immuno Oncology, developing next-generation therapeutics targeting immune suppression in cancer. It is developing novel drugs...